Percheron Therapeutics LimitedASX: PER

Dosing commenced in DMD combination therapy study

Sep 12, 2022 at 3:36 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment